Ventricular tachycardia Medical Services in China

Ventricular tachycardia (VT) is a potentially life-threatening cardiac arrhythmia originating from the ventricles, characterized by three or more consecutive premature ventricular contractions at a rate exceeding 100 beats per minute. It may present with palpitations, lightheadedness, syncope, or sudden cardiac arrest—particularly in patients with structural heart disease such as prior myocardial infarction, cardiomyopathy, or congenital channelopathies. Diagnosis relies on electrocardiography (ECG), Holter monitoring, electrophysiological studies (EPS), and advanced imaging including cardiac MRI to assess substrate. Management encompasses acute interventions (e.g., synchronized cardioversion, antiarrhythmic agents like amiodarone or lidocaine) and long-term strategies—including catheter ablation (especially for idiopathic or scar-related VT), implantable cardioverter-defibrillator (ICD) placement, and guideline-directed medical therapy.

China offers distinct advantages for VT treatment: its leading cardiovascular centers—such as Fu Wai Hospital (National Center for Cardiovascular Diseases) and Shanghai Ruijin Hospital—boast internationally trained electrophysiologists with extensive experience in complex ablation techniques, including substrate-based mapping and high-density electroanatomic mapping. State-of-the-art infrastructure includes 3D electroanatomic mapping systems (CARTO, EnSite), intracardiac echocardiography, and robotic-assisted ablation platforms. Clinical outcomes align with global benchmarks: published data show >85% freedom from recurrent VT at one year post-ablation in selected cohorts, with low procedural complication rates. Crucially, comprehensive care—including EPS, ablation, ICD implantation, and follow-up—is typically 40–60% more cost-effective than in the US or Western Europe, without compromising quality or safety standards.

As a dedicated medical tourism agency, we facilitate seamless access to these resources for international patients: verifying hospital accreditation, coordinating appointments with top-tier electrophysiology teams, providing transparent, all-inclusive pricing (covering diagnostics, procedure, hospital stay, and postoperative monitoring), and delivering end-to-end support—from visa assistance and travel logistics to multilingual clinical coordination and recovery accommodation.

Treatment Options & Itemized Cost Breakdown for Ventricular Tachycardia (Cardiology Department)

Non-Surgical / Conservative Management

*Indicated for stable, non-sustained VT, idiopathic VT, or as bridge/adjunct to ablation.*

• •Antiarrhythmic Medications (Oral):

- *Sotalol*: ¥90–¥260/month ($13–$37) - *Mexiletine*: ¥60–¥180/month ($9–$26)

• •Baseline Diagnostic Workup (mandatory before initiation):

- Echocardiogram (TTE): ¥480 ($68) - Serum electrolytes, troponin, TSH, liver/kidney function: ¥290 ($41)

• •Monitoring Costs:

- Annual echocardiogram: ¥480 ($68)

Surgical / Procedural / Interventional Options

*Eligibility: Sustained VT, ICD shocks, structural heart disease (e.g., prior MI, cardiomyopathy), or drug-refractory idiopathic VT.*

• •Catheter Ablation (Radiofrequency or Cryo):

- *Procedure fee* (including fluoroscopy, 3D mapping system, ablation catheter): ¥38,000–¥52,000 ($5,380–$7,370) - *Hospital stay* (5–7 days, ICU monitoring if high-risk): ¥12,000–¥18,000 ($1,700–$2,550)

• •Implantable Cardioverter-Defibrillator (ICD):

- *Implantation procedure + hospitalization* (3–5 days): ¥22,000–¥31,000 ($3,120–$4,400)

Special / Complex Condition Management

• •VT Storm (≥3 episodes in 24h):

- IV amiodarone loading + sedation + hemodynamic support: ¥1,600/day ($227) - Urgent ablation (within 48h): +¥8,000 ($1,135) surcharge

• •Post-Infarction VT with LVEF <35%:

• •Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC):

- Combined ablation + ICD: ¥135,000–¥168,000 ($19,140–$23,820)

Quick Selection Guide

• •Young, healthy, idiopathic VT (<45 yrs): First-line catheter ablation (¥38,000–¥52,000). Avoid lifelong drugs; cure rate >90%.
• •Elderly (>75 yrs), multiple comorbidities, low ejection fraction: ICD + optimized GDMT, deferring ablation unless recurrent shocks. Budget: ¥87,000–¥143,000.
• •Budget-constrained, stable non-sustained VT: Sotalol + strict follow-up (annual total ~¥2,200, $312); avoid amiodarone due to long-term toxicity monitoring costs.
• •VT storm or recurrent ICD shocks: Urgent ablation + ICU stabilization, regardless of age—cost justified by mortality reduction.